全球转染试剂和仪器市场规模、份额、趋势和成长分析报告（2026-2034年）

预计转染试剂和设备市场将从 2025 年的 20.1 亿美元成长到 2034 年的 40.9 亿美元，2026 年至 2034 年的复合年增长率为 8.21%。

受基因治疗、CRISPR基因编辑和细胞工程研究活性化的推动，全球转染试剂和设备市场正稳步成长。学术机构和生物製药公司高度依赖转染技术将遗传物质导入细胞。对高效递送质体DNA、mRNA和siRNA系统的需求不断增长，推动了化学和物理转染平台的应用。

基因治疗产品线的拓展、研发经费的增加以及能够提高转染效率并最大限度降低细胞毒性的技术进步是推动成长的成长要素。电穿孔设备的自动化和小型化，以及针对难以转染的原代细胞的专用试剂的开发，正在拓展基因治疗的应用领域。此外，向非病毒载体系统的转变也促进了市场需求的成长。

未来的成长将取决于符合GMP规范的临床生产转染解决方案和可扩展的商业性细胞治疗生产平台。透过与自动化实验室系统的整合以及脂质奈米颗粒技术的进步，预计功能将进一步增强。持续创新，专注于可重复性和成本效益，对于保持长期竞争力仍然至关重要。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

• 市场谱系展望
• 渗透率和成长前景分析
• 价值链分析
• 法律规范
  • 标准与合规性
  • 监管影响分析
• 市场动态
  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场挑战
• 波特五力分析
• PESTLE分析

第四章 全球转染试剂与仪器市场：依产品分类

• 市场分析、洞察与预测
• 试剂
• 装置

第五章 全球转染试剂与仪器市场：依方法划分

• 市场分析、洞察与预测
• 电穿孔
• 脂质体
• 颗粒衝击法
• 显微注射
• 腺病毒载体
• 磷酸钙
• DEAE-聚葡萄糖
• 磁珠
• 活性树状树状聚合物
• 雷射感染

第六章 全球转染试剂与仪器市场：依应用划分

• 市场分析、洞察与预测
• 基因表现研究
• 蛋白质生产
• 基因改造模型
• 药物输送
• 癌症研究
• 生物医学研究

第七章 全球转染试剂和仪器市场：依最终用户划分

• 市场分析、洞察与预测
• 学术研究机构
• 製药和生物技术公司

第八章 全球转染试剂和仪器市场：按地区划分

• 区域分析
• 北美市场分析、洞察与预测
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲市场分析、洞察与预测
  • 英国
  • 法国
  • 德国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太市场分析、洞察与预测
  • 印度
  • 日本
  • 韩国
  • 澳洲
  • 东南亚
  • 其他亚太国家
• 拉丁美洲市场分析、洞察与预测
  • 巴西
  • 阿根廷
  • 秘鲁
  • 智利
  • 其他拉丁美洲国家
• 中东和非洲市场分析、洞察与预测
  • 沙乌地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中东和非洲国家

第九章 竞争情势

• 最新趋势
• 公司分类
• 供应链和销售管道合作伙伴（根据现有资讯）
• 市场占有率和市场定位分析（基于现有资讯）
• 供应商情况（基于现有资讯）
• 策略规划

第十章：公司简介

• 主要公司的市占率分析
• 公司简介
  • Thermo Fisher Scientific Inc
  • Promega Corporation
  • Lonza
  • QIAGEN
  • F. Hoffmann-La Roche Ltd
  • Bio-Rad Laboratories Inc
  • Merck KGaA
  • OriGene Technologies Inc
  • MaxCyte
  • Polyplus

The Transfection Reagents and Equipment Market size is expected to reach USD 4.09 Billion in 2034 from USD 2.01 Billion (2025) growing at a CAGR of 8.21% during 2026-2034.

The Global Transfection Reagents and Equipment market is growing steadily due to increased activity in gene therapy, CRISPR gene editing, and cell engineering research. Academic institutions and biopharmaceutical companies rely heavily on transfection technologies for introducing genetic material into cells. Rising demand for efficient delivery systems for plasmid DNA, mRNA, and siRNA is fueling adoption of both chemical and physical transfection platforms.

Growth drivers include expanding gene therapy pipelines, higher research funding, and technological improvements that enhance transfection efficiency while minimizing cytotoxicity. Automation and miniaturization of electroporation instruments, along with development of specialized reagents for hard-to-transfect primary cells, are broadening application areas. The shift toward non-viral delivery systems also supports increasing market demand.

Future growth will be shaped by GMP-compatible transfection solutions for clinical manufacturing and scalable platforms for commercial cell therapy production. Integration with automated laboratory systems and advancements in lipid nanoparticle technologies will further expand capabilities. Continued innovation focused on reproducibility and cost efficiency will remain essential for long-term competitiveness.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

• Reagents
• Equipment

By Method

• Electroporation
• Liposomes
• Particle Bombardment
• Microinjection
• Adenoviral Vectors
• Calcium Phosphate
• DEAE-dextran
• Magnetic Beads
• Activated Dendrimers
• Laserfection

By Application

• Gene Expression Studies
• Protein Production
• Transgenic Models
• Therapeutic Delivery
• Cancer Research
• Biomedical Research

By End User

• Academic and Research Institutes
• Pharmaceutical and Biotechnology Companies

COMPANIES PROFILED

• Thermo Fisher Scientific Inc, Promega Corporation, Lonza, QIAGEN, F HoffmannLa Roche Ltd, BioRad Laboratories Inc, Merck KGaA, OriGene Technologies Inc, MaxCyte, Polyplus
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET: BY PRODUCT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product
• 4.2. Reagents Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Equipment Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET: BY METHOD 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Method
• 5.2. Electroporation Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Liposomes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Particle Bombardment Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Microinjection Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Adenoviral Vectors Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.7. Calcium Phosphate Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.8. DEAE-dextran Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.9. Magnetic Beads Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.10. Activated Dendrimers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.11. Laserfection Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET: BY APPLICATION 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Application
• 6.2. Gene Expression Studies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Protein Production Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Transgenic Models Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Therapeutic Delivery Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.6. Cancer Research Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.7. Biomedical Research Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET: BY END USER 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast End User
• 7.2. Academic and Research Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Pharmaceutical and Biotechnology Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT MARKET: BY REGION 2022-2034(USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Product
  • 8.2.2 By Method
  • 8.2.3 By Application
  • 8.2.4 By End User
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Product
  • 8.3.2 By Method
  • 8.3.3 By Application
  • 8.3.4 By End User
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Product
  • 8.4.2 By Method
  • 8.4.3 By Application
  • 8.4.4 By End User
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Product
  • 8.5.2 By Method
  • 8.5.3 By Application
  • 8.5.4 By End User
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 South East Asia
  • 8.5.10 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Product
  • 8.6.2 By Method
  • 8.6.3 By Application
  • 8.6.4 By End User
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL TRANSFECTION REAGENTS AND EQUIPMENT INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 Thermo Fisher Scientific Inc
  • 10.2.2 Promega Corporation
  • 10.2.3 Lonza
  • 10.2.4 QIAGEN
  • 10.2.5 F. Hoffmann-La Roche Ltd
  • 10.2.6 Bio-Rad Laboratories Inc
  • 10.2.7 Merck KGaA
  • 10.2.8 OriGene Technologies Inc
  • 10.2.9 MaxCyte
  • 10.2.10 Polyplus